🇺🇸 FDA
Patent

US 8686143

Compounds useful as inhibitors of Janus kinases

granted A61PA61P1/16A61P11/06

Quick answer

US patent 8686143 (Compounds useful as inhibitors of Janus kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P1/16, A61P11/06, A61P17/06, A61P17/14